nodes	percent_of_prediction	percent_of_DWPC	metapath
Desogestrel—Ethinyl Estradiol—osteoporosis	0.245	1	CrCtD
Desogestrel—polycystic ovary syndrome—Ethinyl Estradiol—osteoporosis	0.188	1	CpDpCtD
Desogestrel—SHBG—osteoporosis	0.097	0.597	CbGaD
Desogestrel—ESR1—osteoporosis	0.0655	0.403	CbGaD
Desogestrel—SHBG—Estropipate—osteoporosis	0.0406	0.229	CbGbCtD
Desogestrel—ESR1—Estropipate—osteoporosis	0.0294	0.165	CbGbCtD
Desogestrel—SHBG—Ethinyl Estradiol—osteoporosis	0.0262	0.147	CbGbCtD
Desogestrel—ESR1—Raloxifene—osteoporosis	0.0196	0.11	CbGbCtD
Desogestrel—ESR1—Ethinyl Estradiol—osteoporosis	0.0189	0.107	CbGbCtD
Desogestrel—SHBG—Estradiol—osteoporosis	0.0169	0.0949	CbGbCtD
Desogestrel—Quinestrol—Estropipate—osteoporosis	0.0161	0.0886	CrCrCtD
Desogestrel—Mestranol—Estropipate—osteoporosis	0.0161	0.0886	CrCrCtD
Desogestrel—Ethinyl Estradiol—Estropipate—osteoporosis	0.0154	0.0844	CrCrCtD
Desogestrel—ESR1—Conjugated Estrogens—osteoporosis	0.0139	0.0782	CbGbCtD
Desogestrel—Quinestrol—Conjugated Estrogens—osteoporosis	0.0122	0.0672	CrCrCtD
Desogestrel—Mestranol—Conjugated Estrogens—osteoporosis	0.0122	0.0672	CrCrCtD
Desogestrel—ESR1—Estradiol—osteoporosis	0.0122	0.0686	CbGbCtD
Desogestrel—Ethinyl Estradiol—Conjugated Estrogens—osteoporosis	0.0116	0.064	CrCrCtD
Desogestrel—Etonogestrel—Ethinyl Estradiol—osteoporosis	0.0114	0.0628	CrCrCtD
Desogestrel—Norelgestromin—Ethinyl Estradiol—osteoporosis	0.0108	0.0594	CrCrCtD
Desogestrel—Quinestrol—Estradiol—osteoporosis	0.0105	0.0578	CrCrCtD
Desogestrel—Mestranol—Estradiol—osteoporosis	0.0105	0.0578	CrCrCtD
Desogestrel—Mestranol—Ethinyl Estradiol—osteoporosis	0.0103	0.0564	CrCrCtD
Desogestrel—Quinestrol—Ethinyl Estradiol—osteoporosis	0.0103	0.0564	CrCrCtD
Desogestrel—Ethinyl Estradiol—Estradiol—osteoporosis	0.01	0.0551	CrCrCtD
Desogestrel—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00894	0.0492	CrCrCtD
Desogestrel—Danazol—Ethinyl Estradiol—osteoporosis	0.00825	0.0454	CrCrCtD
Desogestrel—Norethindrone—Ethinyl Estradiol—osteoporosis	0.00718	0.0395	CrCrCtD
Desogestrel—PGR—Cellular roles of Anthrax toxin—ANTXR2—osteoporosis	0.000494	0.145	CbGpPWpGaD
Desogestrel—ESR1—Signaling events mediated by HDAC Class II—TUBA1B—osteoporosis	0.000159	0.0469	CbGpPWpGaD
Desogestrel—Mood swings—Estropipate—osteoporosis	0.000158	0.00393	CcSEcCtD
Desogestrel—Migraine—Ibandronate—osteoporosis	0.000157	0.00392	CcSEcCtD
Desogestrel—Disturbance in sexual arousal—Calcitriol—osteoporosis	0.000155	0.00387	CcSEcCtD
Desogestrel—Breast disorder—Estropipate—osteoporosis	0.000151	0.00375	CcSEcCtD
Desogestrel—Breast disorder—Raloxifene—osteoporosis	0.000146	0.00363	CcSEcCtD
Desogestrel—Libido decreased—Ethinyl Estradiol—osteoporosis	0.000146	0.00363	CcSEcCtD
Desogestrel—Breast disorder—Ibandronate—osteoporosis	0.000144	0.0036	CcSEcCtD
Desogestrel—Fluid retention—Conjugated Estrogens—osteoporosis	0.000144	0.00359	CcSEcCtD
Desogestrel—Neoplasm—Zoledronate—osteoporosis	0.000142	0.00355	CcSEcCtD
Desogestrel—Quinestrol—ESR1—osteoporosis	0.00014	0.104	CrCbGaD
Desogestrel—Breast pain—Estradiol—osteoporosis	0.000139	0.00347	CcSEcCtD
Desogestrel—Neoplasm—Conjugated Estrogens—osteoporosis	0.000137	0.00342	CcSEcCtD
Desogestrel—Hypertension—Ergocalciferol—osteoporosis	0.000135	0.00336	CcSEcCtD
Desogestrel—Disturbance in sexual arousal—Ethinyl Estradiol—osteoporosis	0.000134	0.00334	CcSEcCtD
Desogestrel—Affect lability—Ethinyl Estradiol—osteoporosis	0.000133	0.00331	CcSEcCtD
Desogestrel—Migraine—Ethinyl Estradiol—osteoporosis	0.000133	0.00331	CcSEcCtD
Desogestrel—Weight increased—Estropipate—osteoporosis	0.000131	0.00327	CcSEcCtD
Desogestrel—PGR—Ovarian Infertility Genes—ESR2—osteoporosis	0.000128	0.0378	CbGpPWpGaD
Desogestrel—Mood swings—Ethinyl Estradiol—osteoporosis	0.000128	0.00319	CcSEcCtD
Desogestrel—Weight increased—Raloxifene—osteoporosis	0.000127	0.00316	CcSEcCtD
Desogestrel—Erythema multiforme—Etidronic acid—osteoporosis	0.000126	0.00314	CcSEcCtD
Desogestrel—Etonogestrel—SHBG—osteoporosis	0.000126	0.0929	CrCbGaD
Desogestrel—Weight decreased—Ibandronate—osteoporosis	0.000125	0.00311	CcSEcCtD
Desogestrel—Weight decreased—Calcitriol—osteoporosis	0.000122	0.00305	CcSEcCtD
Desogestrel—Breast disorder—Ethinyl Estradiol—osteoporosis	0.000122	0.00304	CcSEcCtD
Desogestrel—Breast disorder—Risedronate—osteoporosis	0.000119	0.00297	CcSEcCtD
Desogestrel—Alopecia—Etidronic acid—osteoporosis	0.000118	0.00293	CcSEcCtD
Desogestrel—PGR—Ovarian Infertility Genes—CYP19A1—osteoporosis	0.000117	0.0343	CbGpPWpGaD
Desogestrel—Fluid retention—Estradiol—osteoporosis	0.000115	0.00287	CcSEcCtD
Desogestrel—PGR—Nuclear Receptors—ESR2—osteoporosis	0.000112	0.0329	CbGpPWpGaD
Desogestrel—Neoplasm—Estradiol—osteoporosis	0.00011	0.00273	CcSEcCtD
Desogestrel—Allylestrenol—ESR1—osteoporosis	0.000109	0.0805	CrCbGaD
Desogestrel—Erythema multiforme—Estropipate—osteoporosis	0.000109	0.00272	CcSEcCtD
Desogestrel—Migraine—Conjugated Estrogens—osteoporosis	0.000108	0.0027	CcSEcCtD
Desogestrel—Eye disorder—Estropipate—osteoporosis	0.000108	0.00268	CcSEcCtD
Desogestrel—Erythema multiforme—Alendronate—osteoporosis	0.000107	0.00268	CcSEcCtD
Desogestrel—Mestranol—ESR1—osteoporosis	0.000106	0.0785	CrCbGaD
Desogestrel—Hypersensitivity—Calcium Acetate—osteoporosis	0.000106	0.00265	CcSEcCtD
Desogestrel—Weight increased—Ethinyl Estradiol—osteoporosis	0.000106	0.00265	CcSEcCtD
Desogestrel—Weight decreased—Ethinyl Estradiol—osteoporosis	0.000106	0.00263	CcSEcCtD
Desogestrel—Mood swings—Conjugated Estrogens—osteoporosis	0.000104	0.0026	CcSEcCtD
Desogestrel—Immune system disorder—Estropipate—osteoporosis	0.000104	0.00259	CcSEcCtD
Desogestrel—Eye disorder—Ibandronate—osteoporosis	0.000103	0.00257	CcSEcCtD
Desogestrel—Erythema multiforme—Calcitriol—osteoporosis	0.000102	0.00255	CcSEcCtD
Desogestrel—Alopecia—Estropipate—osteoporosis	0.000102	0.00254	CcSEcCtD
Desogestrel—PGR—Ovarian Infertility Genes—VDR—osteoporosis	0.000102	0.03	CbGpPWpGaD
Desogestrel—Mental disorder—Estropipate—osteoporosis	0.000101	0.00252	CcSEcCtD
Desogestrel—Malnutrition—Estropipate—osteoporosis	0.0001	0.0025	CcSEcCtD
Desogestrel—Alopecia—Alendronate—osteoporosis	0.0001	0.0025	CcSEcCtD
Desogestrel—Immune system disorder—Ibandronate—osteoporosis	9.99e-05	0.00249	CcSEcCtD
Desogestrel—Breast disorder—Conjugated Estrogens—osteoporosis	9.95e-05	0.00248	CcSEcCtD
Desogestrel—Diarrhoea—Calcium Acetate—osteoporosis	9.87e-05	0.00246	CcSEcCtD
Desogestrel—Norgestimate—ESR1—osteoporosis	9.84e-05	0.0725	CrCbGaD
Desogestrel—Alopecia—Ibandronate—osteoporosis	9.77e-05	0.00243	CcSEcCtD
Desogestrel—Mental disorder—Ibandronate—osteoporosis	9.69e-05	0.00241	CcSEcCtD
Desogestrel—Malnutrition—Ibandronate—osteoporosis	9.63e-05	0.0024	CcSEcCtD
Desogestrel—Libido decreased—Estradiol—osteoporosis	9.51e-05	0.00237	CcSEcCtD
Desogestrel—Vomiting—Calcium Acetate—osteoporosis	9.17e-05	0.00228	CcSEcCtD
Desogestrel—Weight increased—Zoledronate—osteoporosis	9e-05	0.00224	CcSEcCtD
Desogestrel—Weight decreased—Zoledronate—osteoporosis	8.94e-05	0.00223	CcSEcCtD
Desogestrel—Levonorgestrel—SHBG—osteoporosis	8.91e-05	0.0657	CrCbGaD
Desogestrel—PGR—Nuclear Receptors—VDR—osteoporosis	8.88e-05	0.0261	CbGpPWpGaD
Desogestrel—PGR—Nuclear Receptor transcription pathway—ESR2—osteoporosis	8.84e-05	0.026	CbGpPWpGaD
Desogestrel—Erythema multiforme—Ethinyl Estradiol—osteoporosis	8.84e-05	0.0022	CcSEcCtD
Desogestrel—Disturbance in sexual arousal—Estradiol—osteoporosis	8.75e-05	0.00218	CcSEcCtD
Desogestrel—Eye disorder—Ethinyl Estradiol—osteoporosis	8.74e-05	0.00218	CcSEcCtD
Desogestrel—Migraine—Estradiol—osteoporosis	8.68e-05	0.00216	CcSEcCtD
Desogestrel—Affect lability—Estradiol—osteoporosis	8.68e-05	0.00216	CcSEcCtD
Desogestrel—Weight increased—Conjugated Estrogens—osteoporosis	8.66e-05	0.00216	CcSEcCtD
Desogestrel—Nausea—Calcium Acetate—osteoporosis	8.57e-05	0.00213	CcSEcCtD
Desogestrel—Eye disorder—Risedronate—osteoporosis	8.52e-05	0.00212	CcSEcCtD
Desogestrel—Etonogestrel—ESR1—osteoporosis	8.51e-05	0.0627	CrCbGaD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	8.49e-05	0.00211	CcSEcCtD
Desogestrel—Immune system disorder—Ethinyl Estradiol—osteoporosis	8.44e-05	0.0021	CcSEcCtD
Desogestrel—Mood swings—Estradiol—osteoporosis	8.35e-05	0.00208	CcSEcCtD
Desogestrel—Hypertension—Ibandronate—osteoporosis	8.31e-05	0.00207	CcSEcCtD
Desogestrel—Alopecia—Ethinyl Estradiol—osteoporosis	8.26e-05	0.00206	CcSEcCtD
Desogestrel—Ethinyl Estradiol—ESR2—osteoporosis	8.24e-05	0.0607	CrCbGaD
Desogestrel—Immune system disorder—Risedronate—osteoporosis	8.23e-05	0.00205	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	8.22e-05	0.00205	CcSEcCtD
Desogestrel—Mental disorder—Ethinyl Estradiol—osteoporosis	8.19e-05	0.00204	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	8.14e-05	0.00203	CcSEcCtD
Desogestrel—Malnutrition—Ethinyl Estradiol—osteoporosis	8.14e-05	0.00203	CcSEcCtD
Desogestrel—Hypertension—Calcitriol—osteoporosis	8.14e-05	0.00203	CcSEcCtD
Desogestrel—Danazol—SHBG—osteoporosis	8.12e-05	0.0598	CrCbGaD
Desogestrel—Eye disorder—Pamidronate—osteoporosis	8.1e-05	0.00202	CcSEcCtD
Desogestrel—Nervous system disorder—Estropipate—osteoporosis	8.03e-05	0.002	CcSEcCtD
Desogestrel—Mental disorder—Risedronate—osteoporosis	7.98e-05	0.00199	CcSEcCtD
Desogestrel—Breast disorder—Estradiol—osteoporosis	7.97e-05	0.00198	CcSEcCtD
Desogestrel—Skin disorder—Estropipate—osteoporosis	7.96e-05	0.00198	CcSEcCtD
Desogestrel—Malnutrition—Risedronate—osteoporosis	7.93e-05	0.00198	CcSEcCtD
Desogestrel—Immune system disorder—Pamidronate—osteoporosis	7.83e-05	0.00195	CcSEcCtD
Desogestrel—Nervous system disorder—Raloxifene—osteoporosis	7.78e-05	0.00194	CcSEcCtD
Desogestrel—Gastrointestinal pain—Etidronic acid—osteoporosis	7.74e-05	0.00193	CcSEcCtD
Desogestrel—Skin disorder—Raloxifene—osteoporosis	7.71e-05	0.00192	CcSEcCtD
Desogestrel—Nervous system disorder—Ibandronate—osteoporosis	7.7e-05	0.00192	CcSEcCtD
Desogestrel—Alopecia—Pamidronate—osteoporosis	7.66e-05	0.00191	CcSEcCtD
Desogestrel—Skin disorder—Ibandronate—osteoporosis	7.63e-05	0.0019	CcSEcCtD
Desogestrel—Nausea—Ergocalciferol—osteoporosis	7.57e-05	0.00189	CcSEcCtD
Desogestrel—Malnutrition—Pamidronate—osteoporosis	7.54e-05	0.00188	CcSEcCtD
Desogestrel—Urticaria—Etidronic acid—osteoporosis	7.52e-05	0.00187	CcSEcCtD
Desogestrel—Ethinyl Estradiol—SHBG—osteoporosis	7.51e-05	0.0554	CrCbGaD
Desogestrel—Abdominal pain—Etidronic acid—osteoporosis	7.49e-05	0.00186	CcSEcCtD
Desogestrel—Skin disorder—Calcitriol—osteoporosis	7.47e-05	0.00186	CcSEcCtD
Desogestrel—Eye disorder—Zoledronate—osteoporosis	7.4e-05	0.00184	CcSEcCtD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—ESR2—osteoporosis	7.37e-05	0.0217	CbGpPWpGaD
Desogestrel—Norethindrone—SHBG—osteoporosis	7.22e-05	0.0532	CrCbGaD
Desogestrel—Erythema multiforme—Conjugated Estrogens—osteoporosis	7.2e-05	0.00179	CcSEcCtD
Desogestrel—Immune system disorder—Zoledronate—osteoporosis	7.15e-05	0.00178	CcSEcCtD
Desogestrel—Eye disorder—Conjugated Estrogens—osteoporosis	7.12e-05	0.00177	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Estropipate—osteoporosis	7.07e-05	0.00176	CcSEcCtD
Desogestrel—PGR—Nuclear Receptor transcription pathway—VDR—osteoporosis	7.02e-05	0.0207	CbGpPWpGaD
Desogestrel—PGR—Cellular roles of Anthrax toxin—IL1B—osteoporosis	7.02e-05	0.0206	CbGpPWpGaD
Desogestrel—Alopecia—Zoledronate—osteoporosis	6.99e-05	0.00174	CcSEcCtD
Desogestrel—Hypersensitivity—Etidronic acid—osteoporosis	6.98e-05	0.00174	CcSEcCtD
Desogestrel—Weight increased—Estradiol—osteoporosis	6.93e-05	0.00173	CcSEcCtD
Desogestrel—Mental disorder—Zoledronate—osteoporosis	6.93e-05	0.00173	CcSEcCtD
Desogestrel—Weight decreased—Estradiol—osteoporosis	6.89e-05	0.00172	CcSEcCtD
Desogestrel—Malnutrition—Zoledronate—osteoporosis	6.89e-05	0.00172	CcSEcCtD
Desogestrel—Immune system disorder—Conjugated Estrogens—osteoporosis	6.88e-05	0.00171	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	6.88e-05	0.00171	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Raloxifene—osteoporosis	6.85e-05	0.00171	CcSEcCtD
Desogestrel—Hypertension—Risedronate—osteoporosis	6.85e-05	0.00171	CcSEcCtD
Desogestrel—PGR—Nuclear Receptors—ESR1—osteoporosis	6.79e-05	0.02	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Ibandronate—osteoporosis	6.78e-05	0.00169	CcSEcCtD
Desogestrel—Alopecia—Conjugated Estrogens—osteoporosis	6.73e-05	0.00168	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	6.71e-05	0.00167	CcSEcCtD
Desogestrel—Gastrointestinal pain—Estropipate—osteoporosis	6.7e-05	0.00167	CcSEcCtD
Desogestrel—Mental disorder—Conjugated Estrogens—osteoporosis	6.68e-05	0.00166	CcSEcCtD
Desogestrel—PGR—Nuclear signaling by ERBB4—ESR1—osteoporosis	6.65e-05	0.0196	CbGpPWpGaD
Desogestrel—Malnutrition—Conjugated Estrogens—osteoporosis	6.63e-05	0.00165	CcSEcCtD
Desogestrel—Gastrointestinal pain—Alendronate—osteoporosis	6.6e-05	0.00164	CcSEcCtD
Desogestrel—ESR1—Nuclear Receptors—ESR2—osteoporosis	6.57e-05	0.0193	CbGpPWpGaD
Desogestrel—Levonorgestrel—CYP19A1—osteoporosis	6.54e-05	0.0482	CrCbGaD
Desogestrel—Nervous system disorder—Ethinyl Estradiol—osteoporosis	6.51e-05	0.00162	CcSEcCtD
Desogestrel—Hypertension—Pamidronate—osteoporosis	6.51e-05	0.00162	CcSEcCtD
Desogestrel—Urticaria—Estropipate—osteoporosis	6.51e-05	0.00162	CcSEcCtD
Desogestrel—Gastrointestinal pain—Raloxifene—osteoporosis	6.49e-05	0.00162	CcSEcCtD
Desogestrel—Diarrhoea—Etidronic acid—osteoporosis	6.48e-05	0.00161	CcSEcCtD
Desogestrel—Abdominal pain—Estropipate—osteoporosis	6.48e-05	0.00161	CcSEcCtD
Desogestrel—Skin disorder—Ethinyl Estradiol—osteoporosis	6.45e-05	0.00161	CcSEcCtD
Desogestrel—Gastrointestinal pain—Ibandronate—osteoporosis	6.42e-05	0.0016	CcSEcCtD
Desogestrel—Urticaria—Alendronate—osteoporosis	6.41e-05	0.0016	CcSEcCtD
Desogestrel—Abdominal pain—Alendronate—osteoporosis	6.38e-05	0.00159	CcSEcCtD
Desogestrel—Nervous system disorder—Risedronate—osteoporosis	6.35e-05	0.00158	CcSEcCtD
Desogestrel—Skin disorder—Risedronate—osteoporosis	6.29e-05	0.00157	CcSEcCtD
Desogestrel—Gastrointestinal pain—Calcitriol—osteoporosis	6.29e-05	0.00157	CcSEcCtD
Desogestrel—Abdominal pain—Raloxifene—osteoporosis	6.27e-05	0.00156	CcSEcCtD
Desogestrel—Urticaria—Ibandronate—osteoporosis	6.24e-05	0.00155	CcSEcCtD
Desogestrel—Abdominal pain—Ibandronate—osteoporosis	6.21e-05	0.00155	CcSEcCtD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—ESR2—osteoporosis	6.18e-05	0.0182	CbGpPWpGaD
Desogestrel—Urticaria—Calcitriol—osteoporosis	6.11e-05	0.00152	CcSEcCtD
Desogestrel—Abdominal pain—Calcitriol—osteoporosis	6.08e-05	0.00151	CcSEcCtD
Desogestrel—Hypersensitivity—Estropipate—osteoporosis	6.04e-05	0.0015	CcSEcCtD
Desogestrel—Nervous system disorder—Pamidronate—osteoporosis	6.04e-05	0.0015	CcSEcCtD
Desogestrel—Vomiting—Etidronic acid—osteoporosis	6.02e-05	0.0015	CcSEcCtD
Desogestrel—Levonorgestrel—ESR1—osteoporosis	6.02e-05	0.0444	CrCbGaD
Desogestrel—Rash—Etidronic acid—osteoporosis	5.97e-05	0.00149	CcSEcCtD
Desogestrel—Dermatitis—Etidronic acid—osteoporosis	5.97e-05	0.00149	CcSEcCtD
Desogestrel—Danazol—CYP19A1—osteoporosis	5.96e-05	0.0439	CrCbGaD
Desogestrel—Hypertension—Zoledronate—osteoporosis	5.95e-05	0.00148	CcSEcCtD
Desogestrel—Hypersensitivity—Alendronate—osteoporosis	5.95e-05	0.00148	CcSEcCtD
Desogestrel—Headache—Etidronic acid—osteoporosis	5.93e-05	0.00148	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	5.82e-05	0.00145	CcSEcCtD
Desogestrel—ESR1—AP-1 transcription factor network—COL1A2—osteoporosis	5.81e-05	0.0171	CbGpPWpGaD
Desogestrel—Hypersensitivity—Ibandronate—osteoporosis	5.79e-05	0.00144	CcSEcCtD
Desogestrel—Erythema multiforme—Estradiol—osteoporosis	5.77e-05	0.00144	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	5.73e-05	0.00143	CcSEcCtD
Desogestrel—Eye disorder—Estradiol—osteoporosis	5.7e-05	0.00142	CcSEcCtD
Desogestrel—Hypersensitivity—Calcitriol—osteoporosis	5.67e-05	0.00141	CcSEcCtD
Desogestrel—Nausea—Etidronic acid—osteoporosis	5.63e-05	0.0014	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	5.61e-05	0.0014	CcSEcCtD
Desogestrel—Diarrhoea—Estropipate—osteoporosis	5.61e-05	0.0014	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Risedronate—osteoporosis	5.59e-05	0.00139	CcSEcCtD
Desogestrel—ESR1—AP-1 transcription factor network—NFATC1—osteoporosis	5.52e-05	0.0162	CbGpPWpGaD
Desogestrel—Diarrhoea—Alendronate—osteoporosis	5.52e-05	0.00138	CcSEcCtD
Desogestrel—Nervous system disorder—Zoledronate—osteoporosis	5.51e-05	0.00137	CcSEcCtD
Desogestrel—Immune system disorder—Estradiol—osteoporosis	5.51e-05	0.00137	CcSEcCtD
Desogestrel—Danazol—ESR1—osteoporosis	5.48e-05	0.0404	CrCbGaD
Desogestrel—Skin disorder—Zoledronate—osteoporosis	5.46e-05	0.00136	CcSEcCtD
Desogestrel—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	5.43e-05	0.00135	CcSEcCtD
Desogestrel—Diarrhoea—Raloxifene—osteoporosis	5.43e-05	0.00135	CcSEcCtD
Desogestrel—Alopecia—Estradiol—osteoporosis	5.39e-05	0.00134	CcSEcCtD
Desogestrel—Diarrhoea—Ibandronate—osteoporosis	5.38e-05	0.00134	CcSEcCtD
Desogestrel—PGR—Nuclear Receptor transcription pathway—ESR1—osteoporosis	5.36e-05	0.0158	CbGpPWpGaD
Desogestrel—Mental disorder—Estradiol—osteoporosis	5.34e-05	0.00133	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Pamidronate—osteoporosis	5.31e-05	0.00132	CcSEcCtD
Desogestrel—Nervous system disorder—Conjugated Estrogens—osteoporosis	5.31e-05	0.00132	CcSEcCtD
Desogestrel—Malnutrition—Estradiol—osteoporosis	5.31e-05	0.00132	CcSEcCtD
Desogestrel—Gastrointestinal pain—Risedronate—osteoporosis	5.29e-05	0.00132	CcSEcCtD
Desogestrel—Urticaria—Ethinyl Estradiol—osteoporosis	5.28e-05	0.00131	CcSEcCtD
Desogestrel—Diarrhoea—Calcitriol—osteoporosis	5.26e-05	0.00131	CcSEcCtD
Desogestrel—Skin disorder—Conjugated Estrogens—osteoporosis	5.26e-05	0.00131	CcSEcCtD
Desogestrel—Abdominal pain—Ethinyl Estradiol—osteoporosis	5.25e-05	0.00131	CcSEcCtD
Desogestrel—ESR1—Nuclear Receptors—VDR—osteoporosis	5.21e-05	0.0153	CbGpPWpGaD
Desogestrel—Vomiting—Estropipate—osteoporosis	5.21e-05	0.0013	CcSEcCtD
Desogestrel—ESR1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	5.19e-05	0.0153	CbGpPWpGaD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	5.17e-05	0.0152	CbGpPWpGaD
Desogestrel—Rash—Estropipate—osteoporosis	5.17e-05	0.00129	CcSEcCtD
Desogestrel—Dermatitis—Estropipate—osteoporosis	5.16e-05	0.00129	CcSEcCtD
Desogestrel—Urticaria—Risedronate—osteoporosis	5.14e-05	0.00128	CcSEcCtD
Desogestrel—Headache—Estropipate—osteoporosis	5.13e-05	0.00128	CcSEcCtD
Desogestrel—Vomiting—Alendronate—osteoporosis	5.13e-05	0.00128	CcSEcCtD
Desogestrel—Abdominal pain—Risedronate—osteoporosis	5.12e-05	0.00127	CcSEcCtD
Desogestrel—PGR—Cellular roles of Anthrax toxin—TNF—osteoporosis	5.09e-05	0.015	CbGpPWpGaD
Desogestrel—Rash—Alendronate—osteoporosis	5.09e-05	0.00127	CcSEcCtD
Desogestrel—Dermatitis—Alendronate—osteoporosis	5.08e-05	0.00127	CcSEcCtD
Desogestrel—Ethinyl Estradiol—ESR1—osteoporosis	5.07e-05	0.0374	CrCbGaD
Desogestrel—Headache—Alendronate—osteoporosis	5.06e-05	0.00126	CcSEcCtD
Desogestrel—Vomiting—Raloxifene—osteoporosis	5.05e-05	0.00126	CcSEcCtD
Desogestrel—Gastrointestinal pain—Pamidronate—osteoporosis	5.03e-05	0.00125	CcSEcCtD
Desogestrel—Rash—Raloxifene—osteoporosis	5e-05	0.00125	CcSEcCtD
Desogestrel—Dermatitis—Raloxifene—osteoporosis	5e-05	0.00125	CcSEcCtD
Desogestrel—Vomiting—Ibandronate—osteoporosis	5e-05	0.00124	CcSEcCtD
Desogestrel—Headache—Raloxifene—osteoporosis	4.97e-05	0.00124	CcSEcCtD
Desogestrel—Rash—Ibandronate—osteoporosis	4.95e-05	0.00123	CcSEcCtD
Desogestrel—Dermatitis—Ibandronate—osteoporosis	4.95e-05	0.00123	CcSEcCtD
Desogestrel—Headache—Ibandronate—osteoporosis	4.92e-05	0.00123	CcSEcCtD
Desogestrel—Hypersensitivity—Ethinyl Estradiol—osteoporosis	4.89e-05	0.00122	CcSEcCtD
Desogestrel—Vomiting—Calcitriol—osteoporosis	4.89e-05	0.00122	CcSEcCtD
Desogestrel—Nausea—Estropipate—osteoporosis	4.87e-05	0.00121	CcSEcCtD
Desogestrel—Abdominal pain—Pamidronate—osteoporosis	4.87e-05	0.00121	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Zoledronate—osteoporosis	4.85e-05	0.00121	CcSEcCtD
Desogestrel—Rash—Calcitriol—osteoporosis	4.85e-05	0.00121	CcSEcCtD
Desogestrel—Dermatitis—Calcitriol—osteoporosis	4.84e-05	0.00121	CcSEcCtD
Desogestrel—Headache—Calcitriol—osteoporosis	4.82e-05	0.0012	CcSEcCtD
Desogestrel—Nausea—Alendronate—osteoporosis	4.79e-05	0.00119	CcSEcCtD
Desogestrel—Hypersensitivity—Risedronate—osteoporosis	4.77e-05	0.00119	CcSEcCtD
Desogestrel—Nausea—Raloxifene—osteoporosis	4.71e-05	0.00117	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	4.67e-05	0.00116	CcSEcCtD
Desogestrel—Nausea—Ibandronate—osteoporosis	4.67e-05	0.00116	CcSEcCtD
Desogestrel—Gastrointestinal pain—Zoledronate—osteoporosis	4.6e-05	0.00115	CcSEcCtD
Desogestrel—Hypertension—Estradiol—osteoporosis	4.58e-05	0.00114	CcSEcCtD
Desogestrel—Nausea—Calcitriol—osteoporosis	4.57e-05	0.00114	CcSEcCtD
Desogestrel—Diarrhoea—Ethinyl Estradiol—osteoporosis	4.54e-05	0.00113	CcSEcCtD
Desogestrel—Hypersensitivity—Pamidronate—osteoporosis	4.53e-05	0.00113	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	4.49e-05	0.00112	CcSEcCtD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—ESR1—osteoporosis	4.47e-05	0.0132	CbGpPWpGaD
Desogestrel—Urticaria—Zoledronate—osteoporosis	4.47e-05	0.00111	CcSEcCtD
Desogestrel—Abdominal pain—Zoledronate—osteoporosis	4.44e-05	0.00111	CcSEcCtD
Desogestrel—Diarrhoea—Risedronate—osteoporosis	4.43e-05	0.0011	CcSEcCtD
Desogestrel—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	4.43e-05	0.0011	CcSEcCtD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—osteoporosis	4.33e-05	0.0127	CbGpPWpGaD
Desogestrel—Urticaria—Conjugated Estrogens—osteoporosis	4.3e-05	0.00107	CcSEcCtD
Desogestrel—Abdominal pain—Conjugated Estrogens—osteoporosis	4.28e-05	0.00107	CcSEcCtD
Desogestrel—Nervous system disorder—Estradiol—osteoporosis	4.25e-05	0.00106	CcSEcCtD
Desogestrel—Vomiting—Ethinyl Estradiol—osteoporosis	4.22e-05	0.00105	CcSEcCtD
Desogestrel—Diarrhoea—Pamidronate—osteoporosis	4.21e-05	0.00105	CcSEcCtD
Desogestrel—Skin disorder—Estradiol—osteoporosis	4.21e-05	0.00105	CcSEcCtD
Desogestrel—Rash—Ethinyl Estradiol—osteoporosis	4.19e-05	0.00104	CcSEcCtD
Desogestrel—Dermatitis—Ethinyl Estradiol—osteoporosis	4.18e-05	0.00104	CcSEcCtD
Desogestrel—Headache—Ethinyl Estradiol—osteoporosis	4.16e-05	0.00104	CcSEcCtD
Desogestrel—Hypersensitivity—Zoledronate—osteoporosis	4.14e-05	0.00103	CcSEcCtD
Desogestrel—ESR1—Nuclear Receptor transcription pathway—VDR—osteoporosis	4.12e-05	0.0121	CbGpPWpGaD
Desogestrel—Vomiting—Risedronate—osteoporosis	4.12e-05	0.00103	CcSEcCtD
Desogestrel—Rash—Risedronate—osteoporosis	4.08e-05	0.00102	CcSEcCtD
Desogestrel—Dermatitis—Risedronate—osteoporosis	4.08e-05	0.00102	CcSEcCtD
Desogestrel—Headache—Risedronate—osteoporosis	4.06e-05	0.00101	CcSEcCtD
Desogestrel—Hypersensitivity—Conjugated Estrogens—osteoporosis	3.99e-05	0.000993	CcSEcCtD
Desogestrel—Nausea—Ethinyl Estradiol—osteoporosis	3.94e-05	0.000983	CcSEcCtD
Desogestrel—Vomiting—Pamidronate—osteoporosis	3.91e-05	0.000975	CcSEcCtD
Desogestrel—Rash—Pamidronate—osteoporosis	3.88e-05	0.000967	CcSEcCtD
Desogestrel—Dermatitis—Pamidronate—osteoporosis	3.88e-05	0.000966	CcSEcCtD
Desogestrel—Headache—Pamidronate—osteoporosis	3.86e-05	0.00096	CcSEcCtD
Desogestrel—Diarrhoea—Zoledronate—osteoporosis	3.85e-05	0.000958	CcSEcCtD
Desogestrel—Nausea—Risedronate—osteoporosis	3.85e-05	0.000958	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Estradiol—osteoporosis	3.74e-05	0.000932	CcSEcCtD
Desogestrel—Diarrhoea—Conjugated Estrogens—osteoporosis	3.7e-05	0.000923	CcSEcCtD
Desogestrel—Nausea—Pamidronate—osteoporosis	3.66e-05	0.000911	CcSEcCtD
Desogestrel—Vomiting—Zoledronate—osteoporosis	3.57e-05	0.00089	CcSEcCtD
Desogestrel—Rash—Zoledronate—osteoporosis	3.54e-05	0.000883	CcSEcCtD
Desogestrel—Gastrointestinal pain—Estradiol—osteoporosis	3.54e-05	0.000883	CcSEcCtD
Desogestrel—Dermatitis—Zoledronate—osteoporosis	3.54e-05	0.000882	CcSEcCtD
Desogestrel—Headache—Zoledronate—osteoporosis	3.52e-05	0.000877	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—KL—osteoporosis	3.5e-05	0.0103	CbGpPWpGaD
Desogestrel—Vomiting—Conjugated Estrogens—osteoporosis	3.44e-05	0.000857	CcSEcCtD
Desogestrel—Urticaria—Estradiol—osteoporosis	3.44e-05	0.000857	CcSEcCtD
Desogestrel—Abdominal pain—Estradiol—osteoporosis	3.42e-05	0.000853	CcSEcCtD
Desogestrel—Rash—Conjugated Estrogens—osteoporosis	3.41e-05	0.00085	CcSEcCtD
Desogestrel—Dermatitis—Conjugated Estrogens—osteoporosis	3.41e-05	0.000849	CcSEcCtD
Desogestrel—Headache—Conjugated Estrogens—osteoporosis	3.39e-05	0.000845	CcSEcCtD
Desogestrel—Nausea—Zoledronate—osteoporosis	3.34e-05	0.000832	CcSEcCtD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—IGF1—osteoporosis	3.24e-05	0.00955	CbGpPWpGaD
Desogestrel—Nausea—Conjugated Estrogens—osteoporosis	3.22e-05	0.000801	CcSEcCtD
Desogestrel—Hypersensitivity—Estradiol—osteoporosis	3.19e-05	0.000795	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	3.06e-05	0.009	CbGpPWpGaD
Desogestrel—Diarrhoea—Estradiol—osteoporosis	2.96e-05	0.000738	CcSEcCtD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	2.84e-05	0.00837	CbGpPWpGaD
Desogestrel—Vomiting—Estradiol—osteoporosis	2.75e-05	0.000686	CcSEcCtD
Desogestrel—Rash—Estradiol—osteoporosis	2.73e-05	0.00068	CcSEcCtD
Desogestrel—Dermatitis—Estradiol—osteoporosis	2.73e-05	0.00068	CcSEcCtD
Desogestrel—Headache—Estradiol—osteoporosis	2.71e-05	0.000676	CcSEcCtD
Desogestrel—Nausea—Estradiol—osteoporosis	2.57e-05	0.000641	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	2.54e-05	0.00746	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—LEP—osteoporosis	2.42e-05	0.00713	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—IRS2—osteoporosis	2.4e-05	0.00705	CbGpPWpGaD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—MYC—osteoporosis	2.33e-05	0.00684	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—ESR1—osteoporosis	2.24e-05	0.00659	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—IRS1—osteoporosis	2.16e-05	0.00636	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—IRS1—osteoporosis	2.09e-05	0.00616	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—KL—osteoporosis	2.05e-05	0.00604	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CYP19A1—osteoporosis	1.98e-05	0.00582	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—IL6R—osteoporosis	1.96e-05	0.00578	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—U2AF1—osteoporosis	1.92e-05	0.00565	CbGpPWpGaD
Desogestrel—ESR1—FOXM1 transcription factor network—MYC—osteoporosis	1.91e-05	0.00563	CbGpPWpGaD
Desogestrel—ESR1—LKB1 signaling events—MYC—osteoporosis	1.88e-05	0.00552	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	1.8e-05	0.00531	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—MYC—osteoporosis	1.78e-05	0.00523	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—TNF—osteoporosis	1.66e-05	0.00487	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—IL1B—osteoporosis	1.54e-05	0.00454	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—ESR2—osteoporosis	1.53e-05	0.00449	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—SOST—osteoporosis	1.44e-05	0.00423	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—RPL24—osteoporosis	1.43e-05	0.0042	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—IRS2—osteoporosis	1.41e-05	0.00414	CbGpPWpGaD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—osteoporosis	1.37e-05	0.00402	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PTH1R—osteoporosis	1.3e-05	0.00383	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CALCR—osteoporosis	1.3e-05	0.00383	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—MYC—osteoporosis	1.3e-05	0.00383	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—TGFB1—osteoporosis	1.3e-05	0.00382	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—MYC—osteoporosis	1.27e-05	0.00374	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—TGFB1—osteoporosis	1.27e-05	0.00373	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—IRS1—osteoporosis	1.23e-05	0.00363	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—IRS1—osteoporosis	1.23e-05	0.00361	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—VDR—osteoporosis	1.21e-05	0.00357	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—IL6R—osteoporosis	1.15e-05	0.00339	CbGpPWpGaD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	1.13e-05	0.00333	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—U2AF1—osteoporosis	1.13e-05	0.00331	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—IL6—osteoporosis	1.1e-05	0.00322	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MGLL—osteoporosis	1.03e-05	0.00304	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—LRP5—osteoporosis	1.01e-05	0.00297	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—LRP6—osteoporosis	9.65e-06	0.00284	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—IL6—osteoporosis	9.55e-06	0.00281	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	9.47e-06	0.00279	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—ESR1—osteoporosis	9.26e-06	0.00273	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—ESR2—osteoporosis	8.96e-06	0.00264	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—IL6—osteoporosis	8.75e-06	0.00258	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—SOST—osteoporosis	8.44e-06	0.00249	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—RPL24—osteoporosis	8.37e-06	0.00246	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—PSMA2—osteoporosis	8.23e-06	0.00242	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—PSMA5—osteoporosis	8.23e-06	0.00242	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TLN1—osteoporosis	8.15e-06	0.0024	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PTH1R—osteoporosis	7.64e-06	0.00225	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CALCR—osteoporosis	7.64e-06	0.00225	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—ESR2—osteoporosis	7.35e-06	0.00216	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—VDR—osteoporosis	7.11e-06	0.00209	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—P4HB—osteoporosis	7.03e-06	0.00207	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—osteoporosis	6.87e-06	0.00202	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PTH—osteoporosis	6.84e-06	0.00201	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—RAP1A—osteoporosis	6.72e-06	0.00198	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CNR2—osteoporosis	6.66e-06	0.00196	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NFATC1—osteoporosis	6.55e-06	0.00193	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—DKK1—osteoporosis	6.5e-06	0.00191	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—WNT1—osteoporosis	6.26e-06	0.00184	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FGA—osteoporosis	6.09e-06	0.00179	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MGLL—osteoporosis	6.07e-06	0.00179	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—LRP5—osteoporosis	5.92e-06	0.00174	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—VDR—osteoporosis	5.84e-06	0.00172	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	5.69e-06	0.00168	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	5.68e-06	0.00167	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—LRP6—osteoporosis	5.66e-06	0.00167	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PTHLH—osteoporosis	5.66e-06	0.00167	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—BMP2—osteoporosis	5.66e-06	0.00167	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FGB—osteoporosis	5.54e-06	0.00163	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PSMA2—osteoporosis	5.35e-06	0.00157	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PSMA5—osteoporosis	5.35e-06	0.00157	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	5.3e-06	0.00156	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—IL6—osteoporosis	5.14e-06	0.00151	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CALCA—osteoporosis	4.99e-06	0.00147	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—PSMA2—osteoporosis	4.83e-06	0.00142	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—PSMA5—osteoporosis	4.83e-06	0.00142	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—MYC—osteoporosis	4.82e-06	0.00142	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TLN1—osteoporosis	4.78e-06	0.00141	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—KL—osteoporosis	4.53e-06	0.00133	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—ESR1—osteoporosis	4.46e-06	0.00131	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—ESR2—osteoporosis	4.32e-06	0.00127	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—P4HB—osteoporosis	4.12e-06	0.00121	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PTH—osteoporosis	4.01e-06	0.00118	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—RAP1A—osteoporosis	3.94e-06	0.00116	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CNR2—osteoporosis	3.91e-06	0.00115	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NFATC1—osteoporosis	3.85e-06	0.00113	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—DKK1—osteoporosis	3.82e-06	0.00112	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—WNT1—osteoporosis	3.68e-06	0.00108	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FGA—osteoporosis	3.58e-06	0.00105	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ADCY5—osteoporosis	3.55e-06	0.00104	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—SPP1—osteoporosis	3.43e-06	0.00101	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—VDR—osteoporosis	3.43e-06	0.00101	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PTHLH—osteoporosis	3.32e-06	0.000978	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—BMP2—osteoporosis	3.32e-06	0.000978	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FGB—osteoporosis	3.25e-06	0.000957	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PSMA5—osteoporosis	3.14e-06	0.000924	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PSMA2—osteoporosis	3.14e-06	0.000924	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IRS2—osteoporosis	3.1e-06	0.000913	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—LEP—osteoporosis	3.04e-06	0.000894	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CALCA—osteoporosis	2.93e-06	0.000861	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ESR1—osteoporosis	2.9e-06	0.000853	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—MYC—osteoporosis	2.83e-06	0.000832	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IRS1—osteoporosis	2.71e-06	0.000797	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—KL—osteoporosis	2.66e-06	0.000782	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—POMC—osteoporosis	2.61e-06	0.000768	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IL6R—osteoporosis	2.55e-06	0.000749	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IGF1—osteoporosis	2.51e-06	0.000739	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—MYC—osteoporosis	2.32e-06	0.000683	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—ADCY5—osteoporosis	2.08e-06	0.000613	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—SPP1—osteoporosis	2.01e-06	0.000593	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IRS2—osteoporosis	1.82e-06	0.000536	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—LEP—osteoporosis	1.78e-06	0.000525	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IRS1—osteoporosis	1.59e-06	0.000468	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—POMC—osteoporosis	1.53e-06	0.000451	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MYC—osteoporosis	1.51e-06	0.000444	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TGFB1—osteoporosis	1.5e-06	0.000443	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IL6R—osteoporosis	1.49e-06	0.00044	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IGF1—osteoporosis	1.47e-06	0.000433	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—MYC—osteoporosis	1.36e-06	0.000401	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IL6—osteoporosis	1.13e-06	0.000334	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MYC—osteoporosis	8.85e-07	0.00026	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TGFB1—osteoporosis	8.83e-07	0.00026	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IL6—osteoporosis	6.65e-07	0.000196	CbGpPWpGaD
